Jury selection is beginning in the next trial of Alabama’s lawsuits against more than 70 pharmaceutical companies for allegedly overcharging the state’s Medicaid program.
A jury is being selected June 17 in the trial against drug companies Novartis Pharmaceuticals and SmithKline Beecham Corp. before Montgomery County Circuit Judge Charles Price. Opening statements in the trial are expected to begin tomorrow.
In the first trial in February, a state court jury awarded the state $215 million in its Medicaid drug price fraud case against AstraZeneca Pharmaceuticals LP.
Novartis produces a number of drugs, including the high blood pressure medications Diovan and Tekturna. SmithKline makes the asthma medication Advair and other prescription drugs.
Topics Alabama
Was this article valuable?
Here are more articles you may enjoy.
Florida Needs More 鈥� Much More 鈥� Wind Mitigation, Say Experts at OIR Summit 
State Farm Agrees to $15M Settlement for Underpaid Vehicle Claims 
Business Interruption Claims Arising From the Middle East Conflict 
State High Court Weighs in on Woman Taken for Organ Donation But Was Still Alive 
